MICHAEL M WICK Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL M WICK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL M WICK. MICHAEL M WICK is President, CEO and Chairman in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX).
Latest Insider Trading Transactions of MICHAEL M WICK
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2010 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | P | 0.75 | 4,600 | 3,470 | 162,391 | 157.8 K to 162.4 K (+2.92 %) |
| Jun 17 2010 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | P | 0.77 | 200 | 154 | 157,791 | 157.6 K to 157.8 K (+0.13 %) |
| Jun 17 2010 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | P | 0.77 | 1,100 | 847 | 157,591 | 156.5 K to 157.6 K (+0.70 %) |
| Jun 17 2010 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | P | 0.77 | 983 | 755 | 156,491 | 155.5 K to 156.5 K (+0.63 %) |
| Jun 17 2010 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | P | 0.76 | 200 | 152 | 155,508 | 155.3 K to 155.5 K (+0.13 %) |
| Jun 17 2010 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | P | 0.76 | 1,300 | 986 | 155,308 | 154 K to 155.3 K (+0.84 %) |
| Jun 17 2010 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | P | 0.76 | 400 | 303 | 154,008 | 153.6 K to 154 K (+0.26 %) |
| Jun 17 2010 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | P | 0.76 | 100 | 76 | 153,608 | 153.5 K to 153.6 K (+0.07 %) |
| Jun 17 2010 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | P | 0.76 | 300 | 227 | 153,508 | 153.2 K to 153.5 K (+0.20 %) |
| Jun 17 2010 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | P | 0.76 | 100 | 76 | 153,208 | 153.1 K to 153.2 K (+0.07 %) |
| Jun 17 2010 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | P | 0.76 | 200 | 151 | 153,108 | 152.9 K to 153.1 K (+0.13 %) |
| Jun 17 2010 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | P | 0.76 | 300 | 227 | 152,908 | 152.6 K to 152.9 K (+0.20 %) |
| Jun 17 2010 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | P | 0.75 | 1,500 | 1,131 | 152,608 | 151.1 K to 152.6 K (+0.99 %) |
| Jun 17 2010 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | P | 0.75 | 8,300 | 6,258 | 151,108 | 142.8 K to 151.1 K (+5.81 %) |
| Jun 17 2010 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | P | 0.75 | 100 | 75 | 142,808 | 142.7 K to 142.8 K (+0.07 %) |
| Jun 17 2010 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | P | 0.75 | 1,600 | 1,206 | 142,708 | 141.1 K to 142.7 K (+1.13 %) |
| Jun 17 2010 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | P | 0.75 | 400 | 301 | 141,108 | 140.7 K to 141.1 K (+0.28 %) |
| Jun 17 2010 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | P | 0.75 | 500 | 377 | 140,708 | 140.2 K to 140.7 K (+0.36 %) |
| Jun 17 2010 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | P | 0.75 | 200 | 150 | 140,208 | 140 K to 140.2 K (+0.14 %) |
| Jun 17 2010 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | P | 0.75 | 7,617 | 5,713 | 140,008 | 132.4 K to 140 K (+5.75 %) |
| Nov 18 2009 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Option Exercise | A | 0.79 | 375,000 | 296,250 | 375,000 | |
| Nov 18 2009 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Option Exercise | A | 0.79 | 550,000 | 434,500 | 550,000 | |
| May 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Option Exercise | M | 1.60 | 33,125 | 53,000 | 0 | |
| May 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Option Exercise | M | 1.60 | 21,875 | 35,000 | 0 | |
| May 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.11 | 1,600 | 3,376 | 132,391 | 134 K to 132.4 K (-1.19 %) |
| May 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.12 | 10,000 | 21,200 | 133,991 | 144 K to 134 K (-6.94 %) |
| May 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.10 | 9,100 | 19,110 | 143,991 | 153.1 K to 144 K (-5.94 %) |
| May 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.09 | 400 | 836 | 153,091 | 153.5 K to 153.1 K (-0.26 %) |
| May 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.08 | 500 | 1,040 | 153,491 | 154 K to 153.5 K (-0.32 %) |
| May 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.08 | 300 | 623 | 153,991 | 154.3 K to 154 K (-0.19 %) |
| May 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.07 | 4,700 | 9,729 | 154,291 | 159 K to 154.3 K (-2.96 %) |
| May 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.06 | 610 | 1,257 | 158,991 | 159.6 K to 159 K (-0.38 %) |
| May 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.06 | 100 | 206 | 159,601 | 159.7 K to 159.6 K (-0.06 %) |
| May 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.01 | 200 | 402 | 159,701 | 159.9 K to 159.7 K (-0.13 %) |
| May 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.05 | 3,000 | 6,150 | 159,901 | 162.9 K to 159.9 K (-1.84 %) |
| May 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.04 | 100 | 204 | 162,901 | 163 K to 162.9 K (-0.06 %) |
| May 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.00 | 24,390 | 48,780 | 163,001 | 187.4 K to 163 K (-13.02 %) |
| May 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | M | 1.60 | 21,875 | 35,000 | 187,391 | 165.5 K to 187.4 K (+13.22 %) |
| May 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | M | 1.60 | 33,125 | 53,000 | 165,516 | 132.4 K to 165.5 K (+25.02 %) |
| Apr 10 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Option Exercise | M | 1.60 | 40,000 | 64,000 | 33,125 | |
| Apr 10 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.49 | 400 | 996 | 132,391 | 132.8 K to 132.4 K (-0.30 %) |
| Apr 10 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.47 | 2,500 | 6,178 | 132,791 | 135.3 K to 132.8 K (-1.85 %) |
| Apr 10 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.47 | 415 | 1,025 | 135,291 | 135.7 K to 135.3 K (-0.31 %) |
| Apr 10 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.42 | 685 | 1,658 | 135,706 | 136.4 K to 135.7 K (-0.50 %) |
| Apr 10 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.41 | 900 | 2,169 | 136,391 | 137.3 K to 136.4 K (-0.66 %) |
| Apr 10 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.40 | 1,000 | 2,401 | 137,291 | 138.3 K to 137.3 K (-0.72 %) |
| Apr 10 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.40 | 3,000 | 7,200 | 138,291 | 141.3 K to 138.3 K (-2.12 %) |
| Apr 10 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.39 | 2,500 | 5,978 | 141,291 | 143.8 K to 141.3 K (-1.74 %) |
| Apr 10 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.39 | 500 | 1,195 | 143,791 | 144.3 K to 143.8 K (-0.35 %) |
| Apr 10 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.38 | 2,500 | 5,953 | 144,291 | 146.8 K to 144.3 K (-1.70 %) |
| Apr 10 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.38 | 500 | 1,190 | 146,791 | 147.3 K to 146.8 K (-0.34 %) |
| Apr 10 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.36 | 1,000 | 2,361 | 147,291 | 148.3 K to 147.3 K (-0.67 %) |
| Apr 10 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.36 | 1,000 | 2,360 | 148,291 | 149.3 K to 148.3 K (-0.67 %) |
| Apr 10 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.35 | 2,100 | 4,937 | 149,291 | 151.4 K to 149.3 K (-1.39 %) |
| Apr 10 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.33 | 1,900 | 4,427 | 151,391 | 153.3 K to 151.4 K (-1.24 %) |
| Apr 10 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.32 | 6,000 | 13,926 | 153,291 | 159.3 K to 153.3 K (-3.77 %) |
| Apr 10 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.31 | 1,100 | 2,541 | 159,291 | 160.4 K to 159.3 K (-0.69 %) |
| Apr 10 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.30 | 2,600 | 5,983 | 160,391 | 163 K to 160.4 K (-1.60 %) |
| Apr 10 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.30 | 500 | 1,150 | 162,991 | 163.5 K to 163 K (-0.31 %) |
| Apr 10 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.29 | 1,000 | 2,291 | 163,491 | 164.5 K to 163.5 K (-0.61 %) |
| Apr 10 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.29 | 900 | 2,061 | 164,491 | 165.4 K to 164.5 K (-0.54 %) |
| Apr 10 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.28 | 3,000 | 6,843 | 165,391 | 168.4 K to 165.4 K (-1.78 %) |
| Apr 10 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.27 | 4,000 | 9,080 | 168,391 | 172.4 K to 168.4 K (-2.32 %) |
| Apr 10 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | M | 1.60 | 40,000 | 64,000 | 172,391 | 132.4 K to 172.4 K (+30.21 %) |
| Mar 11 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Option Exercise | M | 1.60 | 40,000 | 64,000 | 73,125 | |
| Mar 11 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.18 | 2,400 | 5,232 | 132,391 | 134.8 K to 132.4 K (-1.78 %) |
| Mar 11 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.17 | 500 | 1,085 | 134,791 | 135.3 K to 134.8 K (-0.37 %) |
| Mar 11 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.16 | 1,000 | 2,160 | 135,291 | 136.3 K to 135.3 K (-0.73 %) |
| Mar 11 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.15 | 900 | 1,935 | 136,291 | 137.2 K to 136.3 K (-0.66 %) |
| Mar 11 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.14 | 500 | 1,070 | 137,191 | 137.7 K to 137.2 K (-0.36 %) |
| Mar 11 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.14 | 100 | 214 | 137,691 | 137.8 K to 137.7 K (-0.07 %) |
| Mar 11 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.13 | 95 | 203 | 137,791 | 137.9 K to 137.8 K (-0.07 %) |
| Mar 11 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.13 | 3,005 | 6,401 | 137,886 | 140.9 K to 137.9 K (-2.13 %) |
| Mar 11 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.13 | 600 | 1,275 | 140,891 | 141.5 K to 140.9 K (-0.42 %) |
| Mar 11 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.12 | 6,500 | 13,780 | 141,491 | 148 K to 141.5 K (-4.39 %) |
| Mar 11 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.12 | 188 | 398 | 147,991 | 148.2 K to 148 K (-0.13 %) |
| Mar 11 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.11 | 500 | 1,056 | 148,179 | 148.7 K to 148.2 K (-0.34 %) |
| Mar 11 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.11 | 2,312 | 4,878 | 148,679 | 151 K to 148.7 K (-1.53 %) |
| Mar 11 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.09 | 100 | 209 | 150,991 | 151.1 K to 151 K (-0.07 %) |
| Mar 11 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.07 | 100 | 207 | 151,091 | 151.2 K to 151.1 K (-0.07 %) |
| Mar 11 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.06 | 700 | 1,442 | 151,191 | 151.9 K to 151.2 K (-0.46 %) |
| Mar 11 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.05 | 2,900 | 5,945 | 151,891 | 154.8 K to 151.9 K (-1.87 %) |
| Mar 11 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.04 | 800 | 1,632 | 154,791 | 155.6 K to 154.8 K (-0.51 %) |
| Mar 11 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.02 | 200 | 404 | 155,591 | 155.8 K to 155.6 K (-0.13 %) |
| Mar 11 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.02 | 100 | 202 | 155,791 | 155.9 K to 155.8 K (-0.06 %) |
| Mar 11 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.01 | 100 | 201 | 155,891 | 156 K to 155.9 K (-0.06 %) |
| Mar 11 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.01 | 300 | 602 | 155,991 | 156.3 K to 156 K (-0.19 %) |
| Mar 11 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.00 | 16,100 | 32,200 | 156,291 | 172.4 K to 156.3 K (-9.34 %) |
| Mar 11 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | M | 1.60 | 40,000 | 64,000 | 172,391 | 132.4 K to 172.4 K (+30.21 %) |
| Mar 05 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Option Exercise | A | 2.19 | 250,000 | 547,500 | 250,000 | |
| Mar 05 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Option Exercise | A | 2.19 | 350,000 | 766,500 | 350,000 | |
| Feb 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Option Exercise | M | 1.60 | 40,000 | 64,000 | 113,125 | |
| Feb 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.60 | 3,500 | 9,104 | 132,391 | 135.9 K to 132.4 K (-2.58 %) |
| Feb 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.61 | 4,369 | 11,403 | 135,891 | 140.3 K to 135.9 K (-3.11 %) |
| Feb 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.61 | 2,000 | 5,222 | 140,260 | 142.3 K to 140.3 K (-1.41 %) |
| Feb 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.60 | 14,024 | 36,462 | 142,260 | 156.3 K to 142.3 K (-8.97 %) |
| Feb 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.59 | 1,000 | 2,591 | 156,284 | 157.3 K to 156.3 K (-0.64 %) |
| Feb 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.59 | 9,142 | 23,678 | 157,284 | 166.4 K to 157.3 K (-5.49 %) |
| Feb 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.58 | 5,118 | 13,204 | 166,426 | 171.5 K to 166.4 K (-2.98 %) |
| Feb 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 2.57 | 847 | 2,177 | 171,544 | 172.4 K to 171.5 K (-0.49 %) |
| Feb 13 2008 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | M | 1.60 | 40,000 | 64,000 | 172,391 | 132.4 K to 172.4 K (+30.21 %) |
| Dec 12 2007 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Option Exercise | M | 1.60 | 249,000 | 398,400 | 0 | |
| Dec 12 2007 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 3.51 | 200 | 702 | 132,391 | 132.6 K to 132.4 K (-0.15 %) |
| Dec 12 2007 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 3.67 | 900 | 3,303 | 132,591 | 133.5 K to 132.6 K (-0.67 %) |
| Dec 12 2007 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 3.62 | 10,100 | 36,562 | 133,491 | 143.6 K to 133.5 K (-7.03 %) |
| Dec 12 2007 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 3.60 | 9,400 | 33,840 | 143,591 | 153 K to 143.6 K (-6.14 %) |
| Dec 12 2007 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 3.57 | 86,528 | 308,905 | 152,991 | 239.5 K to 153 K (-36.13 %) |
| Dec 12 2007 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 3.56 | 5,900 | 21,004 | 239,519 | 245.4 K to 239.5 K (-2.40 %) |
| Dec 12 2007 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 3.55 | 19,702 | 69,942 | 245,419 | 265.1 K to 245.4 K (-7.43 %) |
| Dec 12 2007 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 3.54 | 2,070 | 7,328 | 265,121 | 267.2 K to 265.1 K (-0.77 %) |
| Dec 12 2007 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 3.53 | 11,200 | 39,536 | 267,191 | 278.4 K to 267.2 K (-4.02 %) |
| Dec 12 2007 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 3.52 | 1,000 | 3,520 | 278,391 | 279.4 K to 278.4 K (-0.36 %) |
| Dec 12 2007 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 3.50 | 1,400 | 4,900 | 279,391 | 280.8 K to 279.4 K (-0.50 %) |
| Dec 12 2007 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Sell | S | 3.48 | 600 | 2,088 | 280,791 | 281.4 K to 280.8 K (-0.21 %) |
| Dec 12 2007 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | M | 1.60 | 249,000 | 398,400 | 281,391 | 32.4 K to 281.4 K (+768.73 %) |
| Aug 14 2006 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Buy | P | 15.94 | 6,000 | 95,615 | 32,391 | 26.4 K to 32.4 K (+22.74 %) |
| Mar 13 2006 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Option Exercise | A | 20.30 | 100,000 | 2,030,000 | 100,000 | |
| Mar 13 2006 | MBVX | MABVAX THERAPEUTIC ... | WICK MICHAEL M | President, CEO and ... | Option Exercise | A | 20.30 | 140,000 | 2,842,000 | 140,000 |
Page: 1